+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
From
Heart Failure - Epidemiology forecast- 2032 - Product Thumbnail Image

Heart Failure - Epidemiology forecast- 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Acute Coronary Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Acute Coronary Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pulmonary Embolism - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pulmonary Embolism - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Venous Ulceration (CVU) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Venous Ulceration (CVU) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Congestive Heart Failure (CHF) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Congestive Heart Failure (CHF) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cardiogenic Shock - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cardiogenic Shock - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hypovolemic Shock - Epidemiology Forecast - 2032 - Product Thumbnail Image

Hypovolemic Shock - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Inclisiran - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Inclisiran - Emerging Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
From
From
From
From
From
From
Hypercholesterolemia Global Market Report 2025 - Product Thumbnail Image

Hypercholesterolemia Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Aortic Stenosis Global Market Report 2025 - Product Thumbnail Image

Aortic Stenosis Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more